The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: New features and the ‘Ten Commandments’ of the 2019 Guidelines are discussed by Professor Peter J. Grant and Professor Francesco Cosentino, the Task Force chairmen

Eur Heart J. 2019 Oct 14;40(39):3215-3217. doi: 10.1093/eurheartj/ehz687.

Authors

Peter J Grant¹, Francesco Cosentino²

Affiliations

¹ EASD Chair, Professor of Medicine, University of Leeds UK.
² ESC Chair, Professor of Cardiology, Karolinska Institute & Karolinska University Hospital, Stockholm, Sweden.

PMID: 31608951
DOI: 10.1093/eurheartj/ehz687

No abstract available

MeSH terms

Anticoagulants / therapeutic use*
Aspirin / therapeutic use
Atrial Fibrillation / drug therapy
Blood Pressure
Cardiovascular Diseases / epidemiology*
Cardiovascular Diseases / prevention & control
Cholesterol, LDL / blood
Diabetes Mellitus / blood*
Diabetes Mellitus / drug therapy
Diabetes Mellitus / physiopathology
Humans
Hypoglycemic Agents / pharmacology
Hypoglycemic Agents / therapeutic use*
Practice Guidelines as Topic
Prediabetic State / physiopathology
Risk Factors

Substances

Anticoagulants
Cholesterol, LDL
Hypoglycemic Agents
Aspirin